1. Home
  2. CSLR vs ALVOW Comparison

CSLR vs ALVOW Comparison

Compare CSLR & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSLR
  • ALVOW
  • Stock Information
  • Founded
  • CSLR 2022
  • ALVOW 2013
  • Country
  • CSLR United States
  • ALVOW Luxembourg
  • Employees
  • CSLR N/A
  • ALVOW 999
  • Industry
  • CSLR Semiconductors
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CSLR Technology
  • ALVOW Health Care
  • Exchange
  • CSLR Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • CSLR N/A
  • ALVOW N/A
  • IPO Year
  • CSLR N/A
  • ALVOW N/A
  • Fundamental
  • Price
  • CSLR $1.55
  • ALVOW $1.51
  • Analyst Decision
  • CSLR Buy
  • ALVOW
  • Analyst Count
  • CSLR 2
  • ALVOW 0
  • Target Price
  • CSLR $6.00
  • ALVOW N/A
  • AVG Volume (30 Days)
  • CSLR 384.5K
  • ALVOW 15.0K
  • Earning Date
  • CSLR 05-01-2025
  • ALVOW 02-27-2025
  • Dividend Yield
  • CSLR N/A
  • ALVOW N/A
  • EPS Growth
  • CSLR N/A
  • ALVOW N/A
  • EPS
  • CSLR N/A
  • ALVOW N/A
  • Revenue
  • CSLR $40,797,000.00
  • ALVOW $393,919,000.00
  • Revenue This Year
  • CSLR $12.07
  • ALVOW N/A
  • Revenue Next Year
  • CSLR $284.87
  • ALVOW N/A
  • P/E Ratio
  • CSLR N/A
  • ALVOW N/A
  • Revenue Growth
  • CSLR N/A
  • ALVOW 517.92
  • 52 Week Low
  • CSLR $0.20
  • ALVOW $2.33
  • 52 Week High
  • CSLR $3.37
  • ALVOW $2.33
  • Technical
  • Relative Strength Index (RSI)
  • CSLR 49.47
  • ALVOW N/A
  • Support Level
  • CSLR $1.45
  • ALVOW N/A
  • Resistance Level
  • CSLR $1.77
  • ALVOW N/A
  • Average True Range (ATR)
  • CSLR 0.15
  • ALVOW 0.00
  • MACD
  • CSLR 0.02
  • ALVOW 0.00
  • Stochastic Oscillator
  • CSLR 44.04
  • ALVOW 0.00

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: